Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Alcohol Dehydrogenase Mutant. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel enzyme mutant enables high-purity drug intermediate synthesis with improved conversion rates and industrial scalability for global supply chains.
Patent CN112481226A discloses solvent-tolerant ADH mutants enabling 99.9% conversion for chiral diaryl alcohols, offering a green alternative to costly chemical synthesis.
Patent CN115011573B enables efficient synthesis of chiral alcohols with high substrate loading and reduced cofactor costs for pharmaceutical supply chains.